Purinergic Signalling (2007) 3:83–90 23. Stober CB, Lammas DA, Li CM, Kumararatne DS, Lightman SL, McArdle CA (2001) ATP-mediated killing of Mycobacterium bovis Bacille Calmette-Guerin within human macrophages is calcium dependent and associated with the acidification of mycobac- teria-containing phagosomes. J Immunol 166(10):6276–6286 24. North RA (2002) Molecular physiology of P2X receptors. Physiol Rev 82(4):1013–1067 25. Coutinho-Silva R, Ojcius DM, Gorecki DC, Persechini PM, Bisaggio RC, Mendes AN, Marks J, Burnstock G, Dunn PM (2005) Multiple P2X and P2Y receptor subtypes in mouse J774, spleen and peritoneal macrophages. Biochem Pharmacol 69 (4):641–655 26. Yeung D, Kharidia R, Brown SC, Gorecki DC (2004) Enhanced expression of the P2X4 receptor in Duchenne muscular dystrophy correlates with macrophage invasion. Neurobiol Dis 15(2):212– 220 27. Saunders BM, Fernando SL, Sluyter R, Britton WJ, Wiley JS (2003) A loss-of-function polymorphism in the human P2X7 receptor abolishes ATP-mediated killing of mycobacteria. J Immunol 171(10):5442–5446 28. Shemon AN, Sluyter R, Fernando SL, Clarke AL, Dao-Ung LP, Skarratt KK, Saunders BM, Tan KS, Gu BJ, Fuller SJ, Britton WJ, Petrou S, Wiley JS (2005) A Thr357 to Ser polymorphism in homozygous and compound heterozygous subjects causes absent or reduced P2X7 function and impairs ATP-induced mycobacterial killing by macrophages. J Biol Chem 281(4):2079–2086 29. Fernando SL, Saunders BM, Sluyter R, Skarratt KK, Wiley JS, Britton WJ (2005) Gene dosage determines the negative effects of polymorphic alleles of the P2X7 receptor on adenosine triphos- phate-mediated killing of mycobacteria by human macrophages. J Infect Dis 192(1):149–155 30. Myers AJ, Eilertson B, Fulton SA, Flynn JL, Canaday DH (2005) The purinergic P2X7 receptor is not required for control of pulmonary Mycobacterium tuberculosis infection. Infect Immun 73(5):3192–3195 31. el-Moatassim C, Dubyak GR (1992) A novel pathway for the activation of phospholipase-D by P(2z) purinergic receptors in BAC1.2F5 macrophages. J Biol Chem 267(33):23664–23673 32. Ferrari D, Chiozzi P, Falzoni S, Dal Susino M, Melchiorri L, Baricordi OR, Di Virgilio F (1997) Extracellular ATP triggers IL- 1 beta release by activating the purinergic P2Z receptor of human macrophages. J Immunol 159(3):1451–1458 33. Perregaux DG, Gabel CA (1998) Human monocyte stimulus- coupled IL-1beta posttranslational processing: modulation via monovalent cations. Am J Physiol 275(6 Pt 1):C1538–C1547 34. Falzoni S, Munerati M, Ferrari D, Spisani S, Moretti S, Di Virgilio F (1995) The purinergic P2Z receptor of human macrophage cells. Characterization and possible physiological role. J Clin Invest 95 (3):1207–1216 35. Chiozzi P, Sanz JM, Ferrari D, Falzoni S, Aleotti A, Buell GN, Collo G, Di Virgilio F (1997) Spontaneous cell fusion in macrophage cultures expressing high levels of the P2Z/P2X7 receptor. J Cell Biol 138(3):697–706 36. Hu Y, Fisette PL, Denlinger LC, Guadarrama AG, Sommer JA, Proctor RA, Bertics PJ (1998) Purinergic receptor modulation of lipopolysaccharide signaling and inducible nitric-oxide synthase expression in RAW 264.7 macrophages. J Biol Chem 273 (42):27170–27175 37. Humphreys BD, Dubyak GR (1996) Induction of the P2Z/P2X7 nucleotide receptor and associated phospholipase D activity by lipopolysaccharide and IFN-gamma in the human THP-1 mono- cytic cell line. J Immunol 157(12):5627–5637 38. Humphreys BD, Rice J, Kertesy SB, Dubyak GR (2000) Stress- activated protein kinase/JNK activation and apoptotic induction by the macrophage P2X7 nucleotide receptor. J Biol Chem 275 (35):26792–26798 89 39. Adinolfi E, Pizzirani C, Idzko M, Panther E, Norgauer J, Di Virgilio F, Ferrari D (2005) P2X7 receptor: death or life? Purinergic Signalling 1(3):219–227 40. Di Virgilio F, Chiozzi P, Falzoni S, Ferrari D, Sanz JM, Venketaraman V, Baricordi OR (1998) Cytolytic P2X purinocep- tors. Cell Death Differ 5(3):191–199 41. Fairbairn IP, Stober CB, Kumararatne DS, Lammas DA (2001) ATP-mediated killing of intracellular mycobacteria by macro- phages is a P2X7-dependent process inducing bacterial death by phagosome–lysosome fusion. J Immunol 167(6):3300–3307 42. Gan H, He X, Duan L, Mirabile-Levens E, Kornfeld H, Remold HG (2005) Enhancement of antimycobacterial activity of macro- phages by stabilization of inner mitochondrial membrane poten- tial. J Infect Dis 191(8):1292–1300 43. Bavoil PM (1994) Determinants of chlamydial pathogenesis in immunity. In: Miller VL, Kaper JB, Portnoy DA, Isberg RR (eds) Molecular genetics of bacterial pathogenesis. ASM Press, Wash- ington, DC, pp 295–308 44. Schachter J (1999) Infection and disease epidemiology. In: Stephens RS (ed) Chlamydia: intracellular biology, pathogenesis, and immunity. ASM Press, Washington, DC, pp 139–169 45. Thylefors B, Negrel AD, Pararajasegaram R, Dadzie KY (1995) Global data on blindness. Bull World Health Organ 73(1):115–121 46. Miller WC, Ford CA, Morris M, Handcock MS, Schmitz JL, Hobbs MM, Cohen MS, Harris KM, Udry JR (2004) Prevalence of chlamydial and gonococcal infections among young adults in the United States. JAMA 291(18):2229–2236 47. Gerbase AC, Rowley JT, Mertens TE (1998) Global epidemiology of sexually transmitted diseases. Lancet 351(Suppl 3):2–4 48. Belland R, Ojcius DM, Byrne GI (2004) Chlamydia. Nat Rev Microbiol 2(7):530–531 49. Campbell LA, Kuo CC (2004) Chlamydia pneumoniae—an infectious risk factor for atherosclerosis? Nat Rev Microbiol 2 (1):23–32 50. La Verda D, Byrne GI (1994) Interactions between macrophages and chlamydiae. Immunol Ser 60:381–399 51. Coutinho-Silva R, Stahl L, Raymond M-N, Jungas T, Verbeke P, Burnstock G, Darville T, Ojcius DM (2003) Inhibition of chlamydial infectious activity due to P2X7R-dependent phospho- lipase D activation. Immunity 19(3):403–412 52. Coutinho-Silva R, Perfettini J-L, Persechini PM, Dautry-Varsat A, Ojcius DM (2001) Modulation of P2Z/P2X7 receptor activity in macrophages infected with Chlamydia psittaci. Am J Physiol 280 (1):C81–C89 53. Awasthi A, Mathur RK, Saha B (2004) Immune response to Leishmania infection. Indian J Med Res 119(6):238–258 54. Torres-Santos EC, Mantuano MB, Persechini PM, Coutinho-Silva R, Rossi-Bergmann B (2000) Enhanced macrophage permeabili- zation by ATP upon leishmania infection. Drug Dev Res 50(1):61 55. Moore KJ, Matlashewski G (1994) Intracellular infection by Leishmania donovani inhibits macrophage apoptosis. J Immunol 152(6):2930–2937 56. Stafford JL, Neumann NF, Belosevic M (2002) Macrophage- mediated innate host defense against protozoan parasites. Crit Rev Microbiol 28(3):187–248 57. Feng GJ, Goodridge HS, Harnett MM, Wei XQ, Nikolaev AV, Higson AP, Liew FY (1999) Extracellular signal-related kinase (ERK) and p38 mitogen-activated protein (MAP) kinases differen- tially regulate the lipopolysaccharide-mediated induction of induc- ible nitric oxide synthase and IL-12 in macrophages: Leishmania phosphoglycans subvert macrophage IL-12 production by targeting ERK MAP kinase. J Immunol 163(12):6403–6412 58. da Cruz CM, Ventura AL, Schachter J, Costa-Junior HM, Silva Souza HA, Gomes FR, Coutinho-Silva R, Ojcius DM, Persechini PM (2006) Activation of ERK1/2 by extracellular nucleotides in macrophages is mediated by multiple P2 receptors independently